Risk of long covid in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis
BMJ Open Respiratory Research,
Journal Year:
2025,
Volume and Issue:
12(1), P. e002528 - e002528
Published: Jan. 1, 2025
Background
An
estimated
10–30%
of
people
with
COVID-19
experience
debilitating
long-term
symptoms
or
long
covid.
Underlying
health
conditions
associated
chronic
inflammation
may
increase
the
risk
Methods
We
conducted
a
systematic
review
and
meta-analysis
to
examine
whether
covid
was
altered
by
pre-existing
asthma
obstructive
pulmonary
disease
(COPD)
in
adults.
identified
studies
searching
PubMed
Embase
databases
from
inception
13
September
2024.
excluded
that
focused
on
children
defined
only
terms
respiratory
symptoms.
used
random-effects,
restricted
maximum
likelihood
models
analyse
data
pooled
51
studies,
which
included
43
analyses
30
COPD.
The
bias
assessed
using
ROBINS-E
table.
Results
found
41%
increased
odds
(95%
CI
1.29
1.54);
COPD
32%
1.16
1.51).
Pre-existing
asthma,
but
not
COPD,
covid-associated
fatigue.
observed
heterogeneity
results
related
hospitalisation
status.
Potential
confounding
inconsistent
measurement
exposure
outcome
variables
were
among
limitations.
Conclusions
Our
findings
support
hypothesis
covid,
including
fatigue
outcomes
patients
asthma.
Because
targets
tract,
these
inflammatory
lower
tract
could
provide
mechanistic
clues
common
pathway
for
development
sequelae
Language: Английский
Long COVID across SARS‐CoV‐2 variants: Clinical features, pathogenesis, and future directions
MedComm – Future Medicine,
Journal Year:
2024,
Volume and Issue:
3(4)
Published: Dec. 1, 2024
Abstract
Long
coronavirus
disease
(COVID)
is
characterized
by
persistent
symptoms
following
severe
acute
respiratory
syndrome
2
(SARS‐CoV‐2)
infection
and
has
emerged
as
a
significant
health
concern.
As
SARS‐CoV‐2
evolved
from
the
wild‐type
strain
to
Alpha,
Beta,
Delta,
Omicron
variants,
there
may
be
variant‐specific
influence
on
long
COVID
akin
disease.
This
review
aims
summarize
our
current
knowledge
of
influences
in
incidence,
symptom
profile
well
mechanisms
pathogenesis.
We
highlight
that
incidence
lower
with
variants.
The
also
show
some
dependence
different
reduction
cardiopulmonary
more
recent
heterogeneity
related
differences
affecting
immune
system,
viral
persistence,
autoimmunity.
However,
emerging
data
suggest
vaccinations
play
big
role
shaping
presentation
COVID.
ongoing
work
profiles
populations
infected
only
will
beneficial
toward
useful
definitions
development
effective
diagnostic
therapeutic
strategies.
Language: Английский
Analysis of risk factors for long COVID after mild COVID-19 during the Omicron wave in Japan
Hotaka Namie,
No information about this author
Takahiro Takazono,
No information about this author
Rina Kawasaki
No information about this author
et al.
Respiratory Investigation,
Journal Year:
2025,
Volume and Issue:
63(3), P. 303 - 310
Published: March 5, 2025
Language: Английский
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review
Abby E. Rudolph,
No information about this author
Nadine Al Akoury,
No information about this author
Natalija Bogdanenko
No information about this author
et al.
Human Vaccines & Immunotherapeutics,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: March 13, 2025
This
systematic
literature
review
summarizes
the
evidence
across
56
publications
and
pre-prints
(January
2020–July
2023)
with
low-risk
of
bias
based
on
JBI
critical
appraisal,
that
report
adjusted
estimates
for
relationship
between
COVID-19
vaccination
Post-COVID-19
Condition
(PCC)
by
timing
relative
to
infection
or
PCC-onset.
Comparisons
vaccine
effectiveness
(aVE)
against
≥1
PCC
(vs.
unvaccinated)
study
characteristics
known
impact
burden
VE
other
endpoints
were
possible
31
studies
where
preceded
infection.
Seventy-seven
percent
pre-infection
aVE
statistically
significant
(range:
7%–95%).
Statistically
slightly
higher
mRNA
14%–84%)
than
non-mRNA
vaccines
16%–38%)
ranges
before
during
Omicron
overlapped.
Our
findings
suggest
SARS-CoV-2
reduces
risk
regardless
type,
number
doses
received,
definition,
predominant
variant,
severity
acute
infections
included.
Language: Английский
Cardiac symptoms in patients 3–6 months after contracting COVID-19– data from the polish STOP-COVID registry
BMC Infectious Diseases,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: April 9, 2025
Abstract
Background
Common
complaints
of
long
COVID
patients
are
cardiac
symptoms
such
as
fatigue,
weakness,
and
a
feeling
palpitations.
The
study
aimed
to
investigate
the
clinical
features
with
persistent
cardiological
occurring
within
3
6
months
after
COVID-19.
Differences
in
ambulatory
blood
pressure
monitoring
(ABPM),
Holter
ECG
(electrocardiogram)
Echocardiography
between
people
without
were
evaluated.
We
also
assessed
whether
anxiety
depression
may
be
implicated
outcomes.
Materials
methods
This
was
retrospective
affiliated
STOP-COVID
registry
who
attended
follow-up
visit
3–6
undergoing
present
performed
tests:
ABPM,
Echocardiography.
504
additionally
had
GAD-2
(Generalized
Anxiety
Disorder
2-item)
PHQ-2
(Patient
Health
Questionnaire-2)
tests
performed.
Results
analysis
included
1080
patients.
At
least
1
analyzed
586
(54.3%).
most
common
symptom
fatigue
(38.9%).
Comparing
or
palpitations
showed
that
mean
value
ventricular
extrasystole
higher
former
group
(
p
=
0.011).
symptoms,
there
differences
values
0.022)
<
0.001)
scales,
well
percentage
responses
related
risk
depression.
Conclusion
Cardiological
among
health
issues
must
face
contracting
People
more
excessive
extrasystoles
than
these
symptoms.
Trial
registration
Our
based
on
medical
data
COVID-19
treated
out-patient
basis
Polish
Long-Covid
Cardiovascular
(PoLoCOV-CVD)
(ClinicalTrials.gov
identifier–
NCT05018052,
date
29.05.2020).
Consent
conduct
obtained
from
Bioethics
Committee
District
Medical
Chamber
Lodz
(no.
KB-0115/2021).
Language: Английский
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study
Viruses,
Journal Year:
2024,
Volume and Issue:
16(9), P. 1500 - 1500
Published: Sept. 23, 2024
Post
COVID-19
condition
(PCC)
is
defined
as
ongoing
symptoms
at
≥1
month
after
acute
COVID-19.
We
investigated
the
risk
of
PCC
in
an
international
cohort
according
to
viral
variants.
included
7699
hospitalized
patients
six
centers
(January
2020-June
2023);
a
subset
participants
with
visit
over
year
clinical
recovery
were
analyzed.
Variants
observed
or
estimated
using
Global
Data
Science
Initiative
(GISAID)
data.
Because
returning
for
post
may
have
higher
risk,
and
because
variant
could
be
associated
probability
returning,
we
used
weighted
logistic
regressions.
proportion
effect
wild-type
(WT)
virus
vs.
Omicron
on
PCC,
which
was
mediated
by
Intensive
Care
Unit
(ICU)
admission,
through
mediation
analysis.
In
total,
1317
returned
COVID
median
2.6
(IQR
1.84-3.97)
months
recovery.
WT
present
69.6%
participants,
followed
Alpha
(14.4%),
Delta
(8.9%),
Gamma
(3.9%)
strains
(3.3%).
Among
most
common
manifestations
fatigue
(51.7%),
brain
fog
(32.7%)
respiratory
(37.2%).
reduced
clusters;
conversely,
variants
WT.
42%
appeared
ICU
admission.
A
infection,
suggesting
possible
reduction
burden
time.
non-negligible
seems
increased
disease
severity
during
disease.
Language: Английский